Full text is available at the source.
Abstract
A systematic review and meta-analysis focused on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in idiopathic intracranial hypertension (IIH) has been conducted.
- GLP-1 RAs are being investigated for their potential effects on idiopathic intracranial hypertension.
- The review synthesizes existing studies to evaluate clinical outcomes associated with GLP-1 RA use in IIH patients.
- Metabolic and neurophysiological effects of GLP-1 RAs may contribute to their therapeutic potential in IIH.
Simplified